MRS2 and hereditary disease: Moreover, our data are supported by the findings reported by Bruneel et al. that showed decreased levels of glycosylated HPT in the serum of patients affected by congenital disorders of glycosylation, rare inherited diseases, suggesting that it can be valid as a biomarker with diagnostic relevance for this pathology [50].